Inventor · disambiguated record
Yusheng Wu
Also filed as: WU YUSHENG
46 granted patents·20 pending applications·506 citations·filing 1999–2022
98Inventor score
Files withSCHERING CORP12TYK MEDICINES INC10RIB X PHARMACEUTICALS INC7MELINTA THERAPEUTICS INC6ZHU ZHAONING6
Top patents by PatentIndex Score
66 records- 0198US6329395B1Neuropeptide Y5 receptor antagonistsSCHERING CORP·Filed 1999·Granted Dec 11, 2001·186 cites·9 claims
- 0295US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0394US7148219B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2005·Granted Dec 12, 2006·28 cites·71 claims
- 0493US6969726B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2004·Granted Nov 29, 2005·44 cites·104 claims
- 0591US6894063B2Substituted urea neuropeptide Y Y5 Receptor antagonistsSCHERING CORP·Filed 2002·Granted May 17, 2005·24 cites·17 claims
- 0689US9193731B2Antimicrobial compounds and methods of making and using the sameDUFFY ERIN M·Filed 2010·Granted Nov 24, 2015·12 cites·7 claims
- 0789US7456206B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2006·Granted Nov 25, 2008·8 cites·14 claims
- 0888US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 0988US7129259B2Halogenated biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2004·Granted Oct 31, 2006·31 cites·111 claims
- 1087US7705026B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2008·Granted Apr 27, 2010·5 cites·14 claims
- 1186US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 1286US7973067B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2008·Granted Jul 5, 2011·6 cites·22 claims
- 1386US6946476B2Heteroaryl urea neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2002·Granted Sep 20, 2005·16 cites·21 claims
- 1485US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 1585US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 1685US8278334B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2009·Granted Oct 2, 2012·7 cites·10 claims
- 1784US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 1880US7662816B2Cyclic amine BACE-1 inhibitors having a benzamide substituentSCHERING CORP·Filed 2004·Granted Feb 16, 2010·11 cites·25 claims
- 1979US7309704B2Heteroaryl urea neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2005·Granted Dec 18, 2007·2 cites·15 claims
- 2077US8242112B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2011·Granted Aug 14, 2012·2 cites·4 claims
- 2176US8202843B2Macrocyclic compounds and methods of making and using the sameFARMER JAY J·Filed 2005·Granted Jun 19, 2012·2 cites·16 claims
- 2275US8541427B2Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their useSTAMFORD ANDREW W·Filed 2009·Granted Sep 24, 2013·2 cites·21 claims
- 2375US6982267B2Heteroaryl urea neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2001·Granted Jan 3, 2006·9 cites·16 claims
- 2474US8178513B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2009·Granted May 15, 2012·1 cites·13 claims
- 2574US8168641B2Aspartyl protease inhibitorsWU YUSHENG·Filed 2007·Granted May 1, 2012·2 cites·21 claims
- 2674US6936723B2Synthetic salicylihalamides, apicularens and derivatives thereofUNIV TEXAS·Filed 2004·Granted Aug 30, 2005·5 cites·17 claims
- 2772US9062007B2Cyclic amide BACE-1 inhibitors having a benzamide substituentPHARMACOPEIA DRUG DISCOVERY·Filed 2014·Granted Jun 23, 2015·1 cites·6 claims
- 2872US7598250B2Cyclic amine BACE-1 inhibitors having a heterocyclic substituentSCHERING CORP·Filed 2004·Granted Oct 6, 2009·5 cites·34 claims
- 2970US8796465B2Process for the syntheses of triazolesMELINTA THERAPEUTICS INC·Filed 2013·Granted Aug 5, 2014·1 cites·20 claims
- 3069US8629155B2Aspartyl protease inhibitorsWU YUSHENG·Filed 2012·Granted Jan 14, 2014·1 cites·6 claims
- 3169US8623867B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2012·Granted Jan 7, 2014·1 cites·8 claims
- 3268US6617348B1Synthetic salicylihalamides, apicularens and derivatives thereofUT SOUTHWESTERN MEDICAL CT·Filed 2001·Granted Sep 9, 2003·6 cites·36 claims
- 3366US8399660B2Process for the synthesis of triazolesCHEN SHILI·Filed 2006·Granted Mar 19, 2013·1 cites·50 claims
- 3465US9550783B2Biaryl heterocyclic compounds and methods of making and using the sameMELINTA THERAPEUTICS INC·Filed 2014·Granted Jan 24, 2017·0 cites·17 claims
- 3564US8916572B2Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinaseTETRANOV INTERNATIONAL INC·Filed 2013·Granted Dec 23, 2014·2 cites·18 claims
- 3663US9376400B2Process for the synthesis of triazolesMELINTA THERAPEUTICS INC·Filed 2014·Granted Jun 28, 2016·0 cites·2 claims
- 3762US2014073624A1Biaryl Heterocyclic Compounds and Methods of Making and Using the SameRIB X PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3861US8778980B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Jul 15, 2014·0 cites·15 claims
- 3960US6734209B2Synthetic salicylihalamides, apicularens and derivatives thereofUNIV TEXAS·Filed 2003·Granted May 11, 2004·1 cites·7 claims
- 4060US2015158901A1Macrocyclic compounds and methods of making and using the sameMELINTA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4159US2012010200A1Biaryl Heterocyclic Compounds And Methods Of Making And Using The SameZHOU JIACHENG·Filed 2011·Application pending·0 cites
- 4256US8841263B2Macrocyclic compounds and methods of making and using the sameFARMER JAY J·Filed 2012·Granted Sep 23, 2014·0 cites·3 claims
- 4356US2018066007A1Macrocyclic Compounds And Methods Of Making And Using The SameMELINTA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4456US2010234591A1Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4555US2025129086A1Compound for degrading egfr protein and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 4654US8895741B2Process for the synthesis of biaryl oxazolidinonesWU YUSHENG·Filed 2012·Granted Nov 25, 2014·0 cites·20 claims
- 4751US10882845B2Crystal form of deuterated AZD9291, preparation method therefor, and use thereofTYK MEDICINES INC·Filed 2018·Granted Jan 5, 2021·0 cites·9 claims
- 4850US2005038100A1Substituted urea neuropeptide Y Y5 receptor antagonistsFiled 2004·Application pending·0 cites
- 4950US2025154105A1Polycyclic compound and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 5049US12435089B23-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseasesTYK MEDICINES INC·Filed 2021·Granted Oct 7, 2025·0 cites·11 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yusheng Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →